Shift Bioscience
Developing therapies that target aging at the cellular level.
Developing therapies that target aging at the cellular level.
Sector
Life SciencesCategory
AITherapeutics
Location
Cambridge, United KingdomInitial Investment
2022
Shift Bioscience (Shift) is a Cambridge, UK-based biotechnology company focused on safe cellular reprogramming for rejuvenation. The company leverages a proprietary cellular age clock and an active machine learning approach to discover novel factors for safer cellular rejuvenation without the use of pluripotency-inducing reprogramming genes. Shift aims to enable the development of reprogramming-based therapeutics to prevent and treat age-associated diseases.